157 related articles for article (PubMed ID: 11000679)
21. Distortion-product otoacoustic emission test performance for ototoxicity monitoring.
Reavis KM; McMillan G; Austin D; Gallun F; Fausti SA; Gordon JS; Helt WJ; Konrad-Martin D
Ear Hear; 2011 Feb; 32(1):61-74. PubMed ID: 20625302
[TBL] [Abstract][Full Text] [Related]
22. Effect of aspirin on phase gradient of 2F1-F2 distortion product otoacoustic emissions.
Parazzini M; Hall AJ; Lutman ME; Kapadia S
Hear Res; 2005 Jul; 205(1-2):44-52. PubMed ID: 15953514
[TBL] [Abstract][Full Text] [Related]
23. Hearing loss in vestibular schwannomas: analysis of cochlear function by means of distortion-product otoacoustic emissions.
Ferri GG; Modugno GC; Calbucci F; Ceroni AR; Pirodda A
Auris Nasus Larynx; 2009 Dec; 36(6):644-8. PubMed ID: 19419826
[TBL] [Abstract][Full Text] [Related]
24. Distortion-product otoacoustic emissions and cochlear microphonics: relationships in patients with and without endolymphatic hydrops.
Fetterman BL
Laryngoscope; 2001 Jun; 111(6):946-54. PubMed ID: 11404602
[TBL] [Abstract][Full Text] [Related]
25. Audiometric manifestations of Waardenburg's syndrome.
Oysu C; Baserer N; Tinaz M
Ear Nose Throat J; 2000 Sep; 79(9):704-9. PubMed ID: 11011489
[TBL] [Abstract][Full Text] [Related]
26. Transient-evoked otoacoustic emissions in a group of professional singers who have normal pure-tone hearing thresholds.
Hamdan AL; Abouchacra KS; Zeki Al Hazzouri AG; Zaytoun G
Ear Hear; 2008 Jun; 29(3):360-77. PubMed ID: 18382377
[TBL] [Abstract][Full Text] [Related]
27. [Detection of late ototoxic side effect of cisplatin by distortion otoacoustic emission (DPOAE)].
Biró K; Noszek L; Prekopp P; Nagyiványi K; Géczi L; Gaudi I; Bodrogi I
Magy Onkol; 2006; 50(4):329-35. PubMed ID: 17216007
[TBL] [Abstract][Full Text] [Related]
28. Cochlear origin of early hearing loss in vestibular schwannoma.
Gouveris HT; Victor A; Mann WJ
Laryngoscope; 2007 Apr; 117(4):680-3. PubMed ID: 17429875
[TBL] [Abstract][Full Text] [Related]
29. Aminoglycoside ototoxicity: a human temporal bone study.
Hinojosa R; Nelson EG; Lerner SA; Redleaf MI; Schramm DR
Laryngoscope; 2001 Oct; 111(10):1797-805. PubMed ID: 11801948
[TBL] [Abstract][Full Text] [Related]
30. Changes in input/output function of distortion product otoacoustic emissions during the glycerol test in Ménière's disease.
Sakashita T; Shibata T; Yamane H; Hikawa C
Acta Otolaryngol Suppl; 2004 Oct; (554):26-9. PubMed ID: 15513506
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of cochlear involvement by distortion product otoacoustic emission in Behçet's disease.
Dagli M; Eryilmaz A; Tanrikulu S; Aydin A; Gonul M; Gul U; Gocer C
Auris Nasus Larynx; 2008 Sep; 35(3):333-7. PubMed ID: 17996415
[TBL] [Abstract][Full Text] [Related]
32. [Monitoring ototoxic side effects in streptomycin therapy of tuberculosis patients with transitory evoked otoacoustic emissions TEOAE].
Fürst G; Maurer J; Schlegel J
Pneumologie; 1995 Nov; 49(11):590-5. PubMed ID: 8584531
[TBL] [Abstract][Full Text] [Related]
33. [Evoked otoacoustic emission in conduction of dehydration tests in patients with Meniere's disease].
Levina IuV
Vestn Otorinolaringol; 2004; (4):11-4. PubMed ID: 15496832
[TBL] [Abstract][Full Text] [Related]
34. Distortion product otoacoustic emissions in tinnitus patients.
Onishi ET; Fukuda Y; Suzuki FA
Int Tinnitus J; 2004; 10(1):13-6. PubMed ID: 15379342
[TBL] [Abstract][Full Text] [Related]
35. [Tinnitus in noise-induced hearing impairment].
Kowalska S; Sułkowski W
Med Pr; 2001; 52(5):305-13. PubMed ID: 11828843
[TBL] [Abstract][Full Text] [Related]
36. Non-invasive measurements of intralabyrinthine pressure changes by electrocochleography and otoacoustic emissions.
Büki B; Giraudet F; Avan P
Hear Res; 2009 May; 251(1-2):51-9. PubMed ID: 19233252
[TBL] [Abstract][Full Text] [Related]
37. Cochlear function in facioscapulohumeral muscular dystrophy.
Balatsouras DG; Korres S; Manta P; Panousopoulou A; Vassilopoulos D
Otol Neurotol; 2007 Jan; 28(1):7-10. PubMed ID: 17106430
[TBL] [Abstract][Full Text] [Related]
38. Detection of hearing loss using 2f2-f1 and 2f1-f2 distortion-product otoacoustic emissions.
Fitzgerald TS; Prieve BA
J Speech Lang Hear Res; 2005 Oct; 48(5):1165-86. PubMed ID: 16411804
[TBL] [Abstract][Full Text] [Related]
39. [Distortion product otoacoustic emissions in newborns treated by ototoxic drugs].
Ruggieri-Marone M; Schochat E
Rev Laryngol Otol Rhinol (Bord); 2007; 128(1-2):41-6. PubMed ID: 17633664
[TBL] [Abstract][Full Text] [Related]
40. [The study of distortion products otoacoustic emissions in pseudo-anacousia].
Wang Y
Fa Yi Xue Za Zhi; 2003; 19(1):22-3, 26. PubMed ID: 12725162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
